Noble Roman's, Inc.
NROM · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.6% | 8.5% | 1.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 31.1% | 34.4% | 27.4% | 32.8% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 31% | 25.7% | 18.4% | 7.6% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 15.4% | 9.1% | 3.5% | -4.5% |
| EPS Diluted | 0.029 | 0.015 | 0.005 | -0.009 |
| % Growth | 94.6% | 184.6% | 161.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |